<DOC>
	<DOC>NCT00662831</DOC>
	<brief_summary>The purpose of the study isto see the effect of Fragmin on the healing of diabetic foot ulcers by determining the number of subjects with â‰¥50% reduction in ulcer surface area including intact skin healing.</brief_summary>
	<brief_title>Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin, Low-Molecular-Weight</mesh_term>
	<criteria>Male or female subjects 18 years of age with type 1 or type 2 diabetes. Subjects with peripheral occlusive arterial disease (PAOD) and a neuropathy disability score (NDS) of &gt;3 Subjects who have undergone vascular reconstruction or angioplasty less than 1 month prior to randomization. Subjects with an ulcer grading of 0 or 3 and staging of A, B or D according to the University of Texas wound classification system. Subjects with a known bleeding disorder or evidence of active bleeding.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Diabetic Foot Ulcers Neuroischaemic</keyword>
</DOC>